![](https://beyondspringpharma.com/wp-content/uploads/2022/02/ASH-logo-1024x557.png)
12.2020
American Society of Hematology (ASH) Annual Meeting (2020)
PROTECTIVE-2 (BPI-2358-106): A CONFIRMATORY TRIAL TO DEMONSTRATE SUPERIORITY OF THE PLINABULIN + PEGFLIGASTRIM (PLIN/PEG) COMBINATION vs STANDARD OF CARE PEGFILGASTRIM FOR THE PREVENTION OF CHEMOTHERAPY INDUCED NEUTROPENIA (CIN) IN BREAST CANCER PATIENTS